Featured Research

from universities, journals, and other organizations

Cancer Treatment: Selecting Patients Based On Genotype May Increase Efficacy Of Tamoxifen, Study Suggests

Date:
April 30, 2008
Source:
Journal of the National Cancer Institute
Summary:
Breast cancer patients who carry the wild-type gene required for tamoxifen metabolism may have comparable risk of recurrence when taking tamoxifen or an aromatase inhibitor, according to modeling data. Cytochrome P450 2D6 (CYP2D6) converts tamoxifen into its metabolically active form called endoxifen.

Breast cancer patients who carry the wild-type gene required for tamoxifen metabolism may have comparable risk of recurrence when taking tamoxifen or an aromatase inhibitor, according to modeling data.

Related Articles


Cytochrome P450 2D6 (CYP2D6) converts tamoxifen into its metabolically active form called endoxifen. The enzymes encoded by different variants of the CYP2D6 gene metabolize tamoxifen at different rates. For example, women who carry two copies of the CYP2D6*4 allele have less endoxifen in their blood than women who carry two copies of the wild-type allele for CYP2D6. The lower serum concentration of endoxifen may make tamoxifen less effective for the women with the CYP2D6 *4 allele. However, two large randomized trials, which did not test women for their CYP2D6 genotype, showed that breast cancer survivors who take aromatase inhibitors reduce their risk of recurrence more than those taking tamoxifen.

To estimate whether women with wild-type CYP2D6 might derive more clinical benefit from tamoxifen than from aromatase inhibitors, Rinaa Punglia, M.D., of the Dana-Farber Cancer Institute in Boston and colleagues created a mathematical model. The researchers used estimates about the risk of recurrence from past randomized trials.

Punglia and colleagues calculated that women with wild-type CYP2D6 who take tamoxifen would have approximately the same reduction in the risk of recurrence as was seen for the whole population of women who took aromatase inhibitors in the clinical trial. Therefore, women with wild-type CYP2D6 genotype may derive as much benefit from tamoxifen as from aromatase inhibitors.

"Our model raises the possibility that tailored therapy based on pharmacogenomics could be considered for such women," the authors write.

In an accompanying editorial, Daniel Hayes, M.D., of the University of Michigan Comprehensive Cancer Center in Ann Arbor and colleagues review what is known about tamoxifen metabolism and CYP2D6 allele types and their impact on the risk of recurrence for breast cancer patients.

The editorialists comment that the conclusions by Punglia and colleagues are important because they have brought the field of pharmacogenomics to the attention of breast cancer physicians. However, the analysis was based on limited data and on modeling assumptions and must be viewed with caution. "We do not recommend routine CYP2D6 genotyping for all patients who are considering tamoxifen, although we recognize that there are already selected circumstances in which such knowledge might be helpful," they write.

This research was reported April 29 in the Journal of the National Cancer Institute.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Cancer Treatment: Selecting Patients Based On Genotype May Increase Efficacy Of Tamoxifen, Study Suggests." ScienceDaily. ScienceDaily, 30 April 2008. <www.sciencedaily.com/releases/2008/04/080429170256.htm>.
Journal of the National Cancer Institute. (2008, April 30). Cancer Treatment: Selecting Patients Based On Genotype May Increase Efficacy Of Tamoxifen, Study Suggests. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2008/04/080429170256.htm
Journal of the National Cancer Institute. "Cancer Treatment: Selecting Patients Based On Genotype May Increase Efficacy Of Tamoxifen, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2008/04/080429170256.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins